Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

General differential Hebbian learning: Capturing temporal relations between events in neural networks and the brain.

Zappacosta S, Mannella F, Mirolli M, Baldassarre G.

PLoS Comput Biol. 2018 Aug 28;14(8):e1006227. doi: 10.1371/journal.pcbi.1006227. eCollection 2018 Aug.

2.

Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization.

Terrazzano G, Sica M, Gianfrani C, Mazzarella G, Maurano F, De Giulio B, de Saint-Mezard S, Zanzi D, Maiuri L, Londei M, Jabri B, Troncone R, Auricchio S, Zappacosta S, Carbone E.

J Immunol. 2007 Jul 1;179(1):372-81.

3.

A key role of leptin in the control of regulatory T cell proliferation.

De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G.

Immunity. 2007 Feb;26(2):241-55.

4.

Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis.

De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S, Zappacosta S, Matarese G.

J Clin Invest. 2006 Feb;116(2):447-55. Epub 2006 Jan 12.

5.

Presence of anti-platelet IgM and IgG antibodies in dogs naturally infected by Leishmania infantum.

Terrazzano G, Cortese L, Piantedosi D, Zappacosta S, Di Loria A, Santoro D, Ruggiero G, Ciaramella P.

Vet Immunol Immunopathol. 2006 Apr 15;110(3-4):331-7. Epub 2006 Jan 9.

PMID:
16406554
6.

T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway.

Terrazzano G, Sica M, Becchimanzi C, Costantini S, Rotoli B, Zappacosta S, Alfinito F, Ruggiero G.

J Leukoc Biol. 2005 Jul;78(1):27-36. Epub 2005 Apr 7.

PMID:
15817705
7.

Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.

Matarese G, Carrieri PB, La Cava A, Perna F, Sanna V, De Rosa V, Aufiero D, Fontana S, Zappacosta S.

Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5150-5. Epub 2005 Mar 23.

8.

Helicobacter pylori induces apoptosis of human monocytes but not monocyte-derived dendritic cells: role of the cag pathogenicity island.

Galgani M, Busiello I, Censini S, Zappacosta S, Racioppi L, Zarrilli R.

Infect Immun. 2004 Aug;72(8):4480-5.

9.

GPI-defective monocytes from paroxysmal nocturnal hemoglobinuria patients show impaired in vitro dendritic cell differentiation.

Ruggiero G, Terrazzano G, Becchimanzi C, Sica M, Andretta C, Masci AM, Racioppi L, Rotoli B, Zappacosta S, Alfinito F.

J Leukoc Biol. 2004 Sep;76(3):634-40. Epub 2004 Jun 14.

PMID:
15197238
10.

Cyclic AMP modulates the functional plasticity of immature dendritic cells by inhibiting Src-like kinases through protein kinase A-mediated signaling.

Galgani M, De Rosa V, De Simone S, Leonardi A, D'Oro U, Napolitani G, Masci AM, Zappacosta S, Racioppi L.

J Biol Chem. 2004 Jul 30;279(31):32507-14. Epub 2004 May 27.

11.

Interaction between natural killer and dendritic cells: the role of CD40, CD80 and major histocompatibility complex class i molecules in cytotoxicity induction and interferon-gamma production.

Terrazzano G, Pisanti S, Grimaldi S, Sica M, Fontana S, Carbone E, Zappacosta S, Ruggiero G.

Scand J Immunol. 2004 Apr;59(4):356-62.

12.

Allelic distribution of human leucocyte antigen in historical and recently diagnosed tuberculosis patients in Southern Italy.

Ruggiero G, Cosentini E, Zanzi D, Sanna V, Terrazzano G, Matarese G, Sanduzzi A, Perna F, Zappacosta S.

Immunology. 2004 Mar;111(3):318-22.

13.

Proliferative and cytotoxic response of human natural killer cells exposed to transporter associated with antigen-processing-deficient cells.

Cerboni C, Oberg L, Terrazzano G, Zappacosta S, Carbone E, Kärre K.

Scand J Immunol. 2004 Feb;59(2):159-67.

14.

Leptin as a novel therapeutic target for immune intervention.

Matarese G, Sanna V, Fontana S, Zappacosta S.

Curr Drug Targets Inflamm Allergy. 2002 Mar;1(1):13-22. Review.

PMID:
14561203
15.

HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.

Masci AM, Galgani M, Cassano S, De Simone S, Gallo A, De Rosa V, Zappacosta S, Racioppi L.

J Leukoc Biol. 2003 Dec;74(6):1117-24. Epub 2003 Sep 12.

PMID:
12972513
16.

Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses.

Sanna V, Di Giacomo A, La Cava A, Lechler RI, Fontana S, Zappacosta S, Matarese G.

J Clin Invest. 2003 Jan;111(2):241-50.

17.

Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia.

Masci AM, Palmieri G, Vitiello L, Montella L, Perna F, Orlandi P, Abbate G, Zappacosta S, De Palma R, Racioppi L.

Blood. 2003 Apr 15;101(8):3106-8. Epub 2002 Dec 19.

18.

Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors.

Terrazzano G, Zanzi D, Palomba C, Carbone E, Grimaldi S, Pisanti S, Fontana S, Zappacosta S, Ruggiero G.

J Leukoc Biol. 2002 Aug;72(2):305-11.

PMID:
12149421
19.

Leptin accelerates autoimmune diabetes in female NOD mice.

Matarese G, Sanna V, Lechler RI, Sarvetnick N, Fontana S, Zappacosta S, La Cava A.

Diabetes. 2002 May;51(5):1356-61.

20.

Balancing susceptibility to infection and autoimmunity: a role for leptin?

Matarese G, La Cava A, Sanna V, Lord GM, Lechler RI, Fontana S, Zappacosta S.

Trends Immunol. 2002 Apr;23(4):182-7.

PMID:
11923112
21.

Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males.

Matarese G, Sanna V, Di Giacomo A, Lord GM, Howard JK, Bloom SR, Lechler RI, Fontana S, Zappacosta S.

Eur J Immunol. 2001 May;31(5):1324-32.

22.

Requirement for leptin in the induction and progression of autoimmune encephalomyelitis.

Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, Bloom SR, Lechler RI, Zappacosta S, Fontana S.

J Immunol. 2001 May 15;166(10):5909-16.

23.

Modulation of CD45 tyrosine phosphatase activity by antigen.

Lago Paz F, Galgani M, D'Oro U, Matarese G, Masci AM, Zappacosta S, Racioppi L.

Eur J Immunol. 2001 Mar;31(3):777-82.

24.

The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients.

Montanaro D, Sanna V, Matarese G, Larby BB, Racioppi L, Carrieri PB, Bruno R, Davey NJ, Zappacosta S, Fontana S.

Clin Exp Immunol. 2001 Feb;123(2):288-93.

25.

HLA class I antigen downregulation by interleukin (IL)-10 is predominantly governed by NK-kappaB in the short term and by TAP1+2 in the long term.

Terrazzano G, Romano MF, Turco MC, Salzano S, Ottaiano A, Venuta S, Fontana S, Manzo C, Zappacosta S, Carbone E.

Tissue Antigens. 2000 Apr;55(4):326-32.

PMID:
10852384
26.

Inhibition of human NK cell-mediated killing by CD1 molecules.

Carbone E, Terrazzano G, Melián A, Zanzi D, Moretta L, Porcelli S, Kärre K, Zappacosta S.

J Immunol. 2000 Jun 15;164(12):6130-7.

27.

Recognition of autologous dendritic cells by human NK cells.

Carbone E, Terrazzano G, Ruggiero G, Zanzi D, Ottaiano A, Manzo C, Kärre K, Zappacosta S.

Eur J Immunol. 1999 Dec;29(12):4022-9.

28.

Effects of human immunodeficiency virus type 1 on CD4 lymphocyte subset activation.

Masci AM, Paz FL, Borriello A, Cassano S, Della Pietra V, Stoiber H, Matarese G, Della Ragione F, Zappacosta S, Racioppi L.

Eur J Immunol. 1999 Jun;29(6):1879-89.

29.

A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.

Carbone E, Ruggiero G, Terrazzano G, Palomba C, Manzo C, Fontana S, Spits H, Kärre K, Zappacosta S.

J Exp Med. 1997 Jun 16;185(12):2053-60.

30.

The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling.

Racioppi L, Matarese G, D'Oro U, De Pascale M, Masci AM, Fontana S, Zappacosta S.

Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10360-5.

31.

Natural killer clones recognize specific soluble HLA class I molecules.

Carbone E, Terrazzano G, Colonna M, Tuosto L, Piccolella E, Franksson L, Palazzolo G, Pérez-Villar JJ, Fontana S, Kärre K, Zappacosta S.

Eur J Immunol. 1996 Mar;26(3):683-9.

PMID:
8605938
32.

Cell surface expression of major histocompatibility class I antigens is modulated by P-glycoprotein transporter.

Masci AM, Scala S, Racioppi L, Zappacosta S.

Hum Immunol. 1995 Mar;42(3):245-53.

PMID:
7759313
33.

A novel strategy of c-myc oncogene in NK activity regulation not related to the W6/32 MHC class-I epitope.

La Cava A, Carbone E, Moscarella A, Barcová M, Salzano S, Zappacosta S, Fontana S.

Int J Cancer. 1994 Jul 1;58(1):123-8.

PMID:
7516924
34.

HLA class II molecules transduce accessory signals affecting the CD3 but not the interleukin-2 activation pathway in T blasts.

Di Rosa F, D'Oro U, Ruggiero G, Racioppi L, Acquaviva A, Ferrone S, Fontana S, Zappacosta S.

Hum Immunol. 1993 Dec;38(4):251-60.

PMID:
8138420
35.

NK and LAK susceptibility varies inversely with target cell MHC class I antigen expression in a rat epithelial tumour system.

Carbone E, Racioppi L, La Cava A, Portella G, Velotti F, Zappacosta S, Fontana S.

Scand J Immunol. 1991 Feb;33(2):185-94.

PMID:
2017656
36.

HLA class II molecules on monocytes regulate T cell proliferation through physical interaction in the CD3 activation pathway.

Ruggiero G, Racioppi L, Manzo C, Pirozzi G, D'Oro U, Ferrone S, Zappacosta S, Fontana S.

Eur J Immunol. 1991 Jan;21(1):29-33.

PMID:
1825060
37.

Inhibition by anti-HLA class II monoclonal antibodies of monoclonal antibody OKT3-induced T cell proliferation. Studies at the mRNA level.

Racioppi L, Moscarella A, Ruggiero G, Manzo C, Ferrone S, Fontana S, Zappacosta S.

J Immunol. 1990 Dec 1;145(11):3635-40.

PMID:
1978847
38.

Monoclonal antibody OKT3-induced T cell proliferation: differential role of HLA class II determinants expressed by T cells and monocytes.

Manzo C, Ruggiero G, del Vecchio L, Racioppi L, Pirozzi G, Temponi M, Ferrone S, Fontana S, Zappacosta S.

Cell Immunol. 1990 Jan;125(1):79-91.

PMID:
1688405
39.

The relationship of modulation of major histocompatibility complex class I antigens to retrovirus transformation in rat cell lines.

Racioppi L, Carbone E, Grieco M, Del Vecchio L, Berlingieri MT, Fusco A, Boncinelli E, Zappacosta S, Fontana S.

Cancer Res. 1988 Jul 1;48(13):3816-21.

40.

Heterogeneity in the mitogenic response of peripheral blood mononuclear cells to a pan T monoclonal antibody.

Carandente Giarrusso P, Turco MC, Corbo L, Maio M, Alfinito F, Scala G, Zappacosta S, Venuta S.

Tissue Antigens. 1988 Feb;31(2):59-68.

PMID:
3259736
41.

Inhibition by anti-HLA class II monoclonal antibodies of monocyte-dependent T cell proliferation induced by monoclonal antibody OKT3.

Ruggiero G, Manzo C, Fontana S, Scala G, Pirozzi G, Ferrone S, Zappacosta S.

Eur J Immunol. 1987 Nov;17(11):1585-92.

PMID:
2824212
42.

Expression of major histocompatibility complex class I antigens in normal and transformed rat thyroid epithelial cell lines.

Fontana S, Del Vecchio L, Racioppi L, Carbone E, Pinto A, Colletta G, Zappacosta S.

Cancer Res. 1987 Aug 1;47(15):4178-83.

43.

HLA and prognostic factors in primary breast cancer.

Iaffaioli RV, Maio M, Ruggiero G, De Felice M, Ungaro A, Del Vecchio L, Rosato GB, Bianco AR, Zappacosta S.

Int J Cancer. 1985 May 15;35(5):581-5.

PMID:
3873417
44.

The association between congenital adrenal hyperplasia and HLA in Southern Italy.

Zappacosta S, Maio M, de Felice M, Valentino R.

Ann N Y Acad Sci. 1985;458:46-51. No abstract available.

PMID:
3879130
45.

Modulation of HLA-DR antigens expression in human myeloid leukaemia cells by cytarabine and 5-aza-2'-deoxycytidine.

Pinto A, Maio M, Attadia V, Zappacosta S, Cimino R.

Lancet. 1984 Oct 13;2(8407):867-8. No abstract available.

PMID:
6207398
46.

Strong association between an HLA-DR antigen and thyroid carcinoma.

Panza N, Del Vecchio L, Maio M, De Felice M, Lombardi G, Minozzi M, Zappacosta S.

Tissue Antigens. 1982 Aug;20(2):155-8.

PMID:
6814009
47.

The HLA system in the Campania region: a genetic study.

Zappacosta S, De Felice M, Fiore M, Ferrara GB.

Tissue Antigens. 1980 Oct;16(4):286-93.

PMID:
7466789
48.

The pattern of HLA antigens in two Italian regions.

Zappacosta S, de Felice M, Fiore M, Ferrara GB.

Ric Clin Lab. 1980 Apr-Jun;10(2):405-10.

PMID:
7455530
49.

A novel assocation between HLA and disease: porphyria cutanea tarda and HLA-AW32.

Santoianni P, De Felice M, Ayala F, Budillon G, Zappacosta S.

Dermatologica. 1980;160(6):371-5.

PMID:
7389968
50.

A quantitative study of the clonality in the antibody response of rabbits to the p-azobenzoate group.

Castello G, Buffolano W, Germano A, Zappacosta S.

Immunochemistry. 1976 May;13(5):373-8. No abstract available.

PMID:
945794

Supplemental Content

Loading ...
Support Center